C0282515||Chemoprevention
C0029925||ovarian cancer
C0005595||domestic hen
C0005595||hen
C0599779||animal model
C1511124||in vivo testing
C1254351||agents
C0029925||ovarian carcinogenesis
C0029925||ovarian cancer
C0005595||domestic hen
C0029925||ovarian cancer
C0086418||humans
C0080055||p53
C0026882||mutations
C0029925||ovarian cancer
C0080055||p53
C0038113||stabilizing compound
C0911202||CP-31398
C0005595||hens
C0029925||ovarian cancer
C0008051||egg-laying hens
C0008051||Gallus domesticus
C3815594||randomized
C0012155||diets
C0911202||CP-31398
C0012155||diet
C0911202||CP-31398
C1708745||low-dose treatment
C1708745||low-dose treatment
C0012155||diet
C0911202||CP-31398
C1709056||moderate-dose treatment
C1709056||moderate-dose treatment
C0012155||diet
C0911202||CP-31398
C0242481||high-dose treatment
C0242481||high-dose treatment
C0012155||diet
C0911202||CP-31398
C0005595||Hens
C0205065||ovarian
C0015560||oviductal
C0001418||adenocarcinomas
C0278688||metastatic ovarian cancers
C1709056||moderate-dose treatment
C0242481||high-dose treatment
C1708745||low-dose treatment
C2931869||oviductal cancer
C0911202||CP-31398
C0911202||CP-31398
C0282515||chemoprevention
C1140680||ovarian malignancies
C0153579||oviductal malignancies